These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5160787)

  • 1. [Sulfanilamide compounds with prolonged action in the chemotherapy of experimental cutaneous leishmaniasis].
    Moskalenko Niu ; Pershin GN
    Farmakol Toksikol; 1971; 34(4):449-53. PubMed ID: 5160787
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of the indicators of the effectiveness of chloridine and doxycycline in experimental cutaneous leishmaniasis].
    Khairulin FIa; Taganova OS
    Vestn Dermatol Venerol; 1987; (5):62-5. PubMed ID: 3617922
    [No Abstract]   [Full Text] [Related]  

  • 3. The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis.
    Trotter ER; Peters W; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):299-319. PubMed ID: 7396564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental cutaneous leishmaniasis by liposome-entrapped Pentostam.
    New RR; Chance ML
    Acta Trop; 1980 Sep; 37(3):253-6. PubMed ID: 6106363
    [No Abstract]   [Full Text] [Related]  

  • 5. The experimental chemotherapy of leishmaniasis, VII. Drug responses of L. major and L. mexicana amazonensis, with an analysis of promising chemical leads to new antileishmanial agents.
    Peters W; Trotter ER; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):321-35. PubMed ID: 7396565
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary clinical findings on a new sulfanilamide derivative of prolonged duration of action.
    BRUNO V
    Minerva Med; 1958 Dec; 49(100):4724-6. PubMed ID: 13622384
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of a new sulfanilamide derivative of prolonged action in urinary infections].
    BILIOTTI G
    Minerva Med; 1958 Dec; 49(100):4757-61. PubMed ID: 13622392
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice.
    Fernandes AP; Carvalho FA; Tavares CA; Santiago HC; Castro GA; Tafuri WL; Ferreira LA; Gazzinelli RT
    J Infect Dis; 2001 Jun; 183(11):1646-52. PubMed ID: 11343214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapeutic effectiveness of stibomen in experimental leishmaniasis and trypanosomiasis].
    Pershin GN; Moskalenko NIu
    Med Parazitol (Mosk); 1967; 36(4):422-7. PubMed ID: 5612807
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy in the treatment and control of leishmaniasis.
    Alvar J; Croft S; Olliaro P
    Adv Parasitol; 2006; 61():223-74. PubMed ID: 16735166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
    Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
    Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents.
    Chandra N; Pandey S; Ramesh ; Suryawanshi SN; Gupta S
    Eur J Med Chem; 2006 Jun; 41(6):779-85. PubMed ID: 16697490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
    Nilforoushzadeh MA; Shirani-Bidabadi L; Zolfaghari-Baghbaderani A; Saberi S; Siadat AH; Mahmoudi M
    J Vector Borne Dis; 2008 Dec; 45(4):301-6. PubMed ID: 19248657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American cutaneous leishmaniasis: disappearance of amastigotes from lesions during antimonial therapy.
    Mayrink W; Raso P; Melo MN; Michalick MS; Magalhães PA; Williams P; da Costa CA; Dias M
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):265-9. PubMed ID: 6672988
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of leishmaniasis. Part VII: synthesis and bioevaluation of substituted terpenyl pyrimidines.
    Suryawanshi SN; Bhat BA; Pandey S; Chandra N; Gupta S
    Eur J Med Chem; 2007 Sep; 42(9):1211-7. PubMed ID: 17499393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents.
    Pandey S; Suryawanshi SN; Gupta S; Srivastava VM
    Eur J Med Chem; 2005 Aug; 40(8):751-6. PubMed ID: 15907348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leishmaniasis].
    Kemp M; Theander TG
    Ugeskr Laeger; 2000 Nov; 162(46):6203-7. PubMed ID: 11107967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of leishmaniasis Part VI: synthesis and bioevaluation of some novel terpenyl S,N- and N,N-acetals.
    Suryawanshi SN; Pandey S; Rashmirathi ; Bhatt BA; Gupta S
    Eur J Med Chem; 2007 Apr; 42(4):511-6. PubMed ID: 17178176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral treatment with pyrazole carbohydrazide derivatives against murine infection by Leishmania amazonensis.
    Charret KS; Rodrigues RF; Bernardino AM; Gomes AO; Carvalho AV; Canto-Cavalheiro MM; Leon L; Amaral VF
    Am J Trop Med Hyg; 2009 Apr; 80(4):568-73. PubMed ID: 19346377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.